Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...

Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...

Enacted in 1992 and administered through the Health Resources Services Administration, the 340B Drug Pricing Program requires manufacturers participating in Medicaid to sell drugs at a steep discount ...

A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...

The Trump Administration and 119th Congress will likely be targeting trillions of dollars in savings in the year ahead. Healthcare makes up ...

This past year featured key developments in the prescription drug policy area, including the implementation of significant ...

A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...

HRSA said that drug rebates are illegal under the 340B program and warned the drugmaker it could face significant fines or lose its eligibility for Medicaid or Medicare Part B participation if it ...